Continuous biomanufacturing offers the potential for more agile, flexible production with improved robustness through the elimination of process steps, including hold steps, and the use of smaller ...

Scaling-up production of lentiviral vectors (LV)-based therapies is a persistent challenge for biomanufacturers, and one that threatens their development unless commercial-scale production ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...